Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Administration of Ivabradine in Children with Heart Failure
2019-003902-29Phase 2Active
- Sponsor
- Ospedale Pediatrico Bambino Gesù
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of ivabradine in Acute Heart Failure (AHF) and dilated cardiomyopathy (DCM), sponsored by Ospedale Pediatrico Bambino Gesù. Primary endpoint: Primary: Change in heart rate at 14 days. Started May 2021; status: active.
02
Drugs
ivabradine
03
Conditions
Acute Heart Failure (AHF)dilated cardiomyopathy (DCM)
Beyond the preview
Go deeper on 2019-003902-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003902-29.